2023. Therapy for HER2-positive gastric cancer: an overview of the molecular and genetic characteristics of the signaling pathway, the results of clinical trials. Voprosy onkologii. 69, 1 (Mar. 2023), 45–54. DOI:https://doi.org/10.37469/0507-3758-2023-69-1-45-54.